KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Ginkgo Bioworks Holdings (DNA) Receivables - Other (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of Receivables - Other readings, the most recent being $14.5 million for Q4 2025.

  • On a quarterly basis, Receivables - Other rose 28.32% to $14.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $14.5 million, a 28.32% increase, with the full-year FY2025 number at $14.5 million, up 28.32% from a year prior.
  • Receivables - Other hit $14.5 million in Q4 2025 for Ginkgo Bioworks Holdings, up from $11.3 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $14.5 million in Q4 2025 to a low of $300000.0 in Q2 2021.
  • Median Receivables - Other over the past 5 years was $5.5 million (2021), compared with a mean of $6.6 million.
  • Biggest five-year swings in Receivables - Other: surged 2066.67% in 2022 and later crashed 58.47% in 2023.
  • Ginkgo Bioworks Holdings' Receivables - Other stood at $4.6 million in 2021, then skyrocketed by 41.37% to $6.5 million in 2022, then surged by 55.38% to $10.1 million in 2023, then rose by 11.88% to $11.3 million in 2024, then grew by 28.32% to $14.5 million in 2025.
  • The last three reported values for Receivables - Other were $14.5 million (Q4 2025), $11.3 million (Q4 2024), and $10.1 million (Q4 2023) per Business Quant data.